Search results
Vaxart Inc (VXRT) Q1 2024 Earnings Call Transcript Highlights: Promising Developments and ...
GuruFocus.com via Yahoo Finance· 18 minutes agoRevenue: Q1 2024 revenue was $2.2 million, up from $0.7 million in Q1 2023. Cash, Cash Equivalents, and Investments: Ended Q1 2024 with $36.7 million. BARDA Funding: Received ...
University Lab Partners Selected to Lead the Next Generation of the BARDA Accelerator Network as the...
The West Side Index & Gustine Press-Standard· 7 days agoUniversity Lab Partners (ULP), a premier nonprofit wet lab incubator located in Orange County, CA, has been chosen to lead the diagnostics and medical devices hub in the next generation of the ...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials
Investing.com· 1 day agoVaxart, Inc. (NASDAQ: NASDAQ: VXRT ), a biotechnology company specializing in the development of...
BARDA announces first next-generation countermeasure accelerator hubs
Center for Infectious Disease Research and Policy· 6 days agoOne hub focuses on diagnostics and medical devices, and the other targets therapeutics and vaccines.
Spectral AI, Inc. (NASDAQ:MDAI) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoSpectral AI, Inc. (NASDAQ:MDAI) Q1 2024 Earnings Call Transcript May 11, 2024 Spectral AI, Inc....
Spectral AI hails progress towards first sales and pre-FDA clinical trial
Proactive Investors· 6 days agoAt the end of March, cash stood at $10.2 million, up from $4.8 million at the end of December, which...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 11 hours agoPositive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants Expects to initiate Phase 2b study evaluating Vaxart
Asia's Last Wild Lions Live Only 200 Miles from Mumbai
Thrillist Food & Drink· 18 hours agoBouncing across the dry deciduous forest in the eerie pre-dawn hours, we slow, and the engine of our...
OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves Amid ...
GuruFocus.com via Yahoo Finance· 6 days ago:OPK) has several promising pharmaceutical programs set to enter clinical trials, including a multi-specific oncology antibody and a vaccine licensed to Merck. The company has secured non-dilutive ...
Opko Health (OPK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 6 days agoOur collaboration with BARDA is moving forward and provides non-dilutive financing to develop multispecific antibodies against COVID. As work progresses...